| Dr Zachary Boyd, MD | |
|
6650 W 110th St Ste 100, Overland Park, KS 66211-1544 | |
| (913) 491-9299 | |
| (913) 491-3089 |
| Full Name | Dr Zachary Boyd |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 6650 W 110th St Ste 100, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497998967 | NPI | - | NPPES |
| 323A00003 | Other | MO | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 2013027436 (Missouri) | Primary |
| 174400000X | Specialist | 2013027436 (Missouri) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diagnostic Imaging Centers Pa | 7416926613 | 15 |
| Maryland Imaging Network Pc | 6103259304 | 43 |
| Diagnostic Imaging Centers Pa | 7416926613 | 15 |
| Maryland Imaging Network Pc | 6103259304 | 43 |
| Montefiore Medical Center | 3779496021 | 2003 |
| Optum Medical Care Pc | 9931013240 | 997 |
News Archive
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
A new report by University of Kentucky researcher Linda Van Eldik, PhD, describes an experimental drug candidate that may aid patients with traumatic brain injury (TBI).
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announces the publication of preliminary data from an ongoing independent trial of one of its NuQ assays.
Arterial Remodeling Technologies ("ART") announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company's approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.
› Verified 2 days ago
| Entity Name | Diagnostic Imaging Centers Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366529661 PECOS PAC ID: 7416926613 Enrollment ID: O20050721001124 |
News Archive
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
A new report by University of Kentucky researcher Linda Van Eldik, PhD, describes an experimental drug candidate that may aid patients with traumatic brain injury (TBI).
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announces the publication of preliminary data from an ongoing independent trial of one of its NuQ assays.
Arterial Remodeling Technologies ("ART") announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company's approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.
› Verified 2 days ago
| Entity Name | Maryland Imaging Network Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487296471 PECOS PAC ID: 6103259304 Enrollment ID: O20231006000714 |
News Archive
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
A new report by University of Kentucky researcher Linda Van Eldik, PhD, describes an experimental drug candidate that may aid patients with traumatic brain injury (TBI).
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announces the publication of preliminary data from an ongoing independent trial of one of its NuQ assays.
Arterial Remodeling Technologies ("ART") announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company's approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zachary Boyd, MD 6650 W 110th St Ste 200, Overland Park, KS 66211-1545 Ph: (913) 319-8400 | Dr Zachary Boyd, MD 6650 W 110th St Ste 100, Overland Park, KS 66211-1544 Ph: (913) 491-9299 |
News Archive
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
A new report by University of Kentucky researcher Linda Van Eldik, PhD, describes an experimental drug candidate that may aid patients with traumatic brain injury (TBI).
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announces the publication of preliminary data from an ongoing independent trial of one of its NuQ assays.
Arterial Remodeling Technologies ("ART") announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company's approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.
› Verified 2 days ago
Dr. Michael Farber, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 100, Overland Park, KS 66211 Phone: 913-344-9989 Fax: 913-344-9957 | |
Dr. Jeffrey Ralph Conaway, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7363 Fax: 913-498-6699 | |
Dr. Chad M Ruble, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8000 W 110th St, Suite 150, Overland Park, KS 66210 Phone: 913-599-6777 Fax: 913-599-3955 | |
Kimberly Wherry-roys, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Overland Park, KS 66204 Phone: 913-676-2310 | |
Dr. Susanne Marie Chow, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7164 Fax: 913-498-7899 | |
Dr. Michael A Hughes, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7409 Fax: 913-498-7470 | |
Samuel Joseph Hund, Radiology Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 200, Overland Park, KS 66211 Phone: 913-319-8400 |